IMPROVEDD VTE risk score: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(30 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}
{{CMG}}; {{AE}} {{SSH}}, {{SMP}}, {{Anmol}}
 
{{SK}}
==Overview==
==Overview==
The IMPROVEDD risk score, which adds [[D-dimer]] to the conventional IMPROVE score, improves the prediction of [[venous thromboembolism]] events in acutely ill patients within 42 days of hospitalization compared to the IMPROVE score.<ref>{{cite journal |last1=Gibson |first1=CM |date=2017 |title= The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification |url= https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603929#TB17006-7 |journal= Thrombosis Haemostasis |volume= 1 |issue=1 |pages= 56-65 |doi= 10.1055/s-0037-1603929 |access-date=  }}</ref>
The IMPROVEDD VTE Risk Score, which incorporates [[D-dimer]] measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic [[venous thromboembolism]] (including symptomatic [[deep-vein thrombosis]], nonfatal [[pulmonary embolism]], and death related to [[venous thromboembolism]]) events in acutely ill hospitalized patients up to 77 days of hospitalization.


'''Please check the boxes that apply to you to get your individualized IMPROVEDD Risk score for VTE at 42 days after hospitalization:'''
==IMPROVEDD VTE Risk Score==
The IMPROVEDD VTE Risk Score, which incorporates [[D-dimer]] measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic [[venous thromboembolism]] (including symptomatic [[deep-vein thrombosis]], nonfatal [[pulmonary embolism]], and death related to [[venous thromboembolism]]) events in acutely ill hospitalized patients up to 77 days of hospitalization.<ref>{{cite journal | author=Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. |date=2017 |title= The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification |url= https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603929#TB17006-7 |journal= TH Open |volume= 01 |issue=01 |pages= e56-e65 |doi= 10.1055/s-0037-1603929 |access-date=  }}</ref><ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>


{{#widget:IMPROVEDDScore}}
==IMPROVEDD VTE Risk Score Calculator==
Shown below is the calculator for IMPROVEDD Score for VTE (check all the boxes that apply):


==Reference==
{{#widget:IMPROVEDDScore2}}
 
==Interpretation==
* Score = 0: Predicted Risk of Symptomatic VTE is 0.4% at 35-42 days and 0.5% at 77 days
* Score = 1: Predicted Risk of Symptomatic VTE is 0.6% at 35-42 days and 0.7% at 77 days
* Score = 2: Predicted Risk of Symptomatic VTE is 0.8% at 35-42 days and 1.0% at 77 days
* Score = 3: Predicted Risk of Symptomatic VTE is 1.2% at 35-42 days and 1.4% at 77 days
* Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days
* Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days
 
==See also==
*[[IMPROVE risk score calculator]]
 
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Medicine]]
[[Category:Cardiology]]
[[Category:Hematology]]
[[Category:Up-To-Date]]
[[Category:Calculator]]

Latest revision as of 17:42, 30 November 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Seyedmahdi Pahlavani, M.D. [3], Anmol Pitliya, M.B.B.S. M.D.[4]

Synonyms and keywords:

Overview

The IMPROVEDD VTE Risk Score, which incorporates D-dimer measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic venous thromboembolism (including symptomatic deep-vein thrombosis, nonfatal pulmonary embolism, and death related to venous thromboembolism) events in acutely ill hospitalized patients up to 77 days of hospitalization.

IMPROVEDD VTE Risk Score

The IMPROVEDD VTE Risk Score, which incorporates D-dimer measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic venous thromboembolism (including symptomatic deep-vein thrombosis, nonfatal pulmonary embolism, and death related to venous thromboembolism) events in acutely ill hospitalized patients up to 77 days of hospitalization.[1][2]

IMPROVEDD VTE Risk Score Calculator

Shown below is the calculator for IMPROVEDD Score for VTE (check all the boxes that apply):

IMPROVEDD VTE Risk Score Calculator
Variable Score
Prior episode of VTE 3
Thrombophilia 2
Paralysis of the lower extremity during the hospitalization 2
Current malignancy 2
Immobilization for at least 7 days 1
ICU or CCU admission 1
Age more than 60 years 1
D-dimer ≥2× upper limit of normal (or ≥1.0 μg/mL) 2
IMPROVEDD Score:
Predicted Risk of Symptomatic VTE:

Interpretation

  • Score = 0: Predicted Risk of Symptomatic VTE is 0.4% at 35-42 days and 0.5% at 77 days
  • Score = 1: Predicted Risk of Symptomatic VTE is 0.6% at 35-42 days and 0.7% at 77 days
  • Score = 2: Predicted Risk of Symptomatic VTE is 0.8% at 35-42 days and 1.0% at 77 days
  • Score = 3: Predicted Risk of Symptomatic VTE is 1.2% at 35-42 days and 1.4% at 77 days
  • Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days
  • Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days

See also

References

  1. Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. (2017). "The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification". TH Open. 01 (01): e56–e65. doi:10.1055/s-0037-1603929.
  2. Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.